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The possibility that products released by inflamma-
tory cells may playa role in the induction/maintenance 
of psoriasis is suggested by the observation that pso-
riasis, a disease of excess epidermal proliferation, is 
linked to inflammatory events. As an assessment of this 
possibility, the effects of supernatants from antigen 
stimulated and unstimulated peripheral blood mononu-
clear cells fyom normal and psoriatic subjects on the 
proliferation of HeLa cell cultures are presented. Data 
demonstrate that supernatants contain factors which 
both inhibit and enhance cell proliferation, both of which 
are released in greater quantities from antigen stimu-
lated peripheral blood mononuclear cells. Dilutional and 
pulsing experiments show that proliferation enhancing 
factors present in these supernatants have an apparent 
greater affinity for HeLa cells than does the inhibitory 
component. Relative to HeLa cell proliferation in fresh 
media, both antigen stimulated and control supernatants 
from peripheral blood mononuclear cells of subjects with 
psoriasis have significantly less inhibitory and more of 
the enhancing effect than similar supernatants from nor-
mal subjects. Individual, as well as pooled, supernatants 
from subjects with psoriasis demonstrate these differ-
ences. The kinetics of this response are the same, normal 
vs. psori.asis. 
This "net effect" of supernatants from patients with 
psoriasis favoring proliferation is in harmony with the 
concept of inflammatory events playing a role in cell 
proliferation, and may be important in the induction/ 
maintenance of psoriasis. 
Using psoriasis as a model of benign proliferation disease, 
which is characteristically linked to inflammation, we are at-
tempting to elucidate a mechanism where by mononuclear cells 
either enhance or sup pre 's cell proliferation. Clinical observa-
tions have confirmed, on numerous occasions, that the abnor-
mal epidermal proliferation of pso ri asis is somehow related to 
inflammatory events, the Koebner reaction [1). That mononu-
clear cells a re potentially linked is suggested by the data which 
demonstrate that the early lesion of psoriasis is characterized 
by an infiltrate of mononuclear cells, occurring prior to the 
characteristic hyperplasia accompanying a typical lesion of 
psoriasis [2-4]. 
Although products produced by resting and stimulated pe-
ripheral blood mononuclear cells (PBMC) (r ecently termed 
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Abbreviations: 
CPM : counts per minute 
Derm 0: Dermatophyton 0 
HBSS: Han~ 's balanced salt solu tion 
PBMC: peripheral blood mononuclear cells 
PIF: proliferation inhibition factor 
PPO: tuberculin purified protein 
SKSD: streptok inase. streptodol'llase 
Iymphokines, from lymphocytes; and monokines, from mono-
cytes) are usually thought of as modulators of t he immune 
response, t hey effect cells other t han leukocytes. PBMC prod-
ucts (still commonly referred to as lymphokines) directed 
against nonleukocytes include cytotoxic effects (lymphotoxin) 
[5,6], a nd inhibition of cell proliferation. The latte r cytostatic 
Iymphokines have been previously described under a variety of 
names, e.g. proliferation inhibi tion factor (PIF) [7,8] , cloning 
inhibition factor (CIF) [9,10], in terferon (IF) [11-13], inhibitor 
of DNA synthesis (IDS) [14-16], inhibitor of DNA polymerase 
(IDP) [17]. The clinical relevance of cytostatic lymphokine is 
essentially unexplored. Contrawisp., monocytes produce factors 
(monokines) which enhance proliferation of cells other than 
leukocytes [18,19]. 
We have described other aspects of mononuclear cell function 
in psoriasis. Patients with psoriasis have a decreased ability to 
amplify delayed type intradermal skin tests to comm on anti-
gens, and a decreased responsiveness to sensitization with din-
itrochlorobenzene. PBMC from psoriatic subjects have a de-
creased blastogenic response in both t he one-way mixed lym-
phocyte reaction, a nd to a wide range of dosages of mitogen 
[20]. When compared with monocytes from normal subjects, 
monocytes £Tom patients with active a nd inactive psoriasis have 
an increased ability to migrate toward a variety of chemoat-
tractants. In add it ion, monocytes [Tom patients with psoriasis 
have an enhanced ability to spontaneously reduce ni troblue 
tetrazolium [21]. 
The foregoing observations of mononuclear cell fun ction in 
psoriasis caused us to make a more direct assessment of a 
potential aberration in solu ble products of mononuclear cells 
from psoriatic subjects on cell proliferation. No well-defined 
assay exists for quantitating the effect of either inhibitory 01' 
potentiating agents on epidermal cell proli feration in vitro. 
HeLa cells have been used by several investigators to determine 
the effect of soluble products of mononuclear cells ("Iympho-
kines") on t he growth of these cells in vitro [7,8,22]. 
This paper presents the results of a methodology which 
semiquantitatively assessed the amount of cytostatic activity in 
antigen and nonantigen stimulated mononuclear cell superna-
tants from normal a nd psoriatic subj ects. These supernatan ts 
were added to HeLa cell cultures a nd tritiated thymidine uptake 
was utilized to determine the effect of these supernatants on 
HeLa cell proliferation, Evidence is presented which demon-
strates that supernatants of cul tured PBMC enhanced prolif-
eration of HeLa cells, a nd th at PBMC from psoriatic subjects 
produced more of said factor than did those from normal 
subj ects. 
METHODS 
Experimen.tal Subjects 
Informed consent. obtained in accordance with the principles of the 
Declaration of Helsinki, was obtained {'rom 13 psoriatic and 13 normal 
subjects. They had si milar mean ages, age ranges, and sexual distribu -
tion, All psoriatic subjects had their disease for at least 5 yr, and had 
not received topical or systemic therapy for at least 30 days prior to 
skin testing, or PBMC donation. Psoriatic subjects were chosen from a 
group of' volunteers meeting the aforementioned requirements. They 
had varying degrees of clinically active disease; the mean area of skin 
surface involvement being 20%. Five subjects had less than 10% of their 
body surfaces involved, and 6 had greater than 30% involvement. None 
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of t h e patients were undergo ing a n exacerbation or disease, a nd none 
had arthri t is. 
Lymphohine/ Production 
The technique for production and detection of cytostatic lymphokine 
was adopted from the method described by Green et a l [7]. Our usage 
of t he term " lymphokine" implies the origina l usage of this term, i.e., 
products released by PBMC, monoc:ytes a nd lymphocytes. An opera-
tion a l defi J1l tlOn of PIF has been gIven to lymphokll1e preparatIOns 
with cytostatic activ ity in vitro. Chemical puri ty is not implied, nor is 
th e presence of other lymphokine activ ity excluded by this designation. 
Four weeks after s kin testing, as previously described [20], 500 ml of 
blood (heparin 10 units/mil (Hepathrom, Fellows Medica l Mfg. Inc. , 
Anaheim CAl were collected from each of the subjects. This was diluted 
1:2 in Hank's Ba.lanced Salt Solution (HBSS), placed on Ficoll-Paque 
(Pharmacia, Piscataway NJ) and centJ'ifuged at 400 xg for 20 min 
[23]. Mononuclear cells isolated from the interface were su pended in 
RPMI-1640 (Gibco, Grand Island NY), supplemented with gentamycin, 
preservative free, 50 f.lg / ml (Schering Diagnostic Labs, Kenilworth NJ) , 
and 15% AB+ sera (UUMC Blood Bank, SLC UTI. Different ia l, via -
bility a nd cell numbers were determined , and a final suspension 01'.1 X 
10" PBMC/ ml prepared. As previously noted, no differences were noted 
in the percentage of monocytes or lymphocytes isolated from normal 
a nd psoriatic subjects, as judged by microscopic analysis of cells stained 
with Wrigh t's stain [20,21]' The PBMC suspension from each individua l 
was divided into 3 a liquots, labeled A, B, and C. The antigen that 
cau sed the greatest indurat ion on skin testing for that pa t ient was 
add ed to Aliquot A. The a nt igens used were: Streptokinase 38 units/ 
mI, streptodornase 12 units/ml (SKSD) (Lederle Laboratories, Pearl 
River NY), tuberculin pmified protein (PPD) 10 flg / ml, or dermato-
phyton 0 (Derm-O) , a filtrate from Ca.ndida. a.lbica.ns, 0.01 ml of a 1:10 
dilution/ ml (Ho llister-Stier, S pokane W A). These antigen prepa rations 
were dialyzed extensively to remove preservatives, steril ized by fi lt ra-
tion , a nd were the same as those used for skin tests. All a liquots were 
cultured in 30 m.l vo lumes in tissue cul ture flasks in a humidified 
incubator, 5% CO~, 37° for 96 hI'. Aliquot B was trea ted in the same 
fashion as Aliquot A; however, antigen was no t added un til after 
s upernatants were separated from the cells at 96 hI'. Aliquot C was 
treated in a manner s imilar to Aliquot B, only no an t igen was added at 
96 hr. Supernatants from these incubations were sterili:(;ed by fil tration 
and one- ha lf of each a liquot was dia lyzed twice against 20 vol of HBSS 
and once against 20 vol of RPMI- l640 penicill in 100 uni ts, streptomycin 
100 Jig/ml (RPMI-PS) (Gibeo, Grand Isla nd NY). Dia lysis did not effect 
the protein concentration, using the Lowry method for qua nti tation of 
protein content. Aliquots of individua l PBMC supernatants, dia lyzed 
and nondia lyzed, were pooled and st.er ilized by filtration. All sa mples 
were stored at -70°C. 
Semiqu.a.ntita.tive PJF Microa.ssay 
Previously described techniques for aSSaY in~ PIF activity require 
large volu mes of supernatants of stimulated] BMC [7]. Because of 
volume restr ict ions we developed a microtechni{ ue to assay PIF activ-
ity. H eLa (Ohio) cells (Microbiological Associates, Bethesda MD) were 
grown in RPMI-1640-PS with 10% feta l ca lf sera (G ibco, Grand Island 
NY) a nd used as ta rgets after it cou ld be demonstrated that confluence 
of cell growth could be achieved withi n 24 hI' a fter a 1:2 di lu tional 
passage. Assays were started within 2 hr of passage. HeLa cells, 5 x 10'\ 
± 5%, suspended in 0.1 ml RPMI-1640-PS enriched with feta l calf sera 
(15%) were added to each well of a flat-bo t tom microtiter plate (Flow 
Laboratories, E nglewood CAl. Following the addit ion of HeLa cell 
suspensions, the plates were placed in a humidified incubator, 37°. 5% 
CO2. After 4 hI' of culture, 0.1 ml of a freshly thawed supernatant of a 
PBMC culture was added to each well. P lates were returned to the 
incubator; at 24 hI', 0.25 f.lCi of 3H thymidine specific act.ivity 6.7 Cil 
mM (New England Nuc lear , Boston MA) were added to each well or 
the final 24 h1'. Cells from each well of the microtit.er pla te were 
haj'vested wit.h a mu ltiple a ut.omated sa mpl e harvester unit (MASH II, 
Otto Hiller , Madison WS). Following the ini t.ia l harvest, 50 /-Ll of trypsin, 
0.25% (G ibco, Grand Island NY) were added to each of the wells for 20 
min, and wells reharvested wi th the MASH unit. Both filt.ers from the 
harvest of t.he individua l wells were placed in the same vial, scin t.illation 
fluid added (NEN-950 A, New England N uclear, Boston MA) a nd 
radioactivity determined with a Beckman 8100 scintiJlation counting 
system. Microscopic examination of hm'Vested wells revealed that es-
sent ially none of the cells adhered to t.he microtite r plates followin g the 
second ha1'vest. Day to day vm'iabili ty of baseline coun t.s occurr ed, a 
much as 50%. However , the amount of s timulation or suppression seen 
with a pmticular test supernatant was relatively constant. Beca use of 
this variabili ty, data are presen ted as the percent age of the amount of 
3H t.hymidine incorporated into HeLa cells grown in the presence of 
the fre.sh media controls for that experiment., using the foll owing 
formula: 
percentage = 
CPM of 3H thymidine up take 
by HeLa cell in test supernatants 
CPM of' 3H thymidine upta ke 
by HeLa cells in fresh media 
x 100 
This type of index permits the expression of potent ial stimu lation 
(greater than 100%), as well as inhibit ion (less t.han 100%), of HeLa cell 
proliferat ion by the PBMC supernat.ant . 
RESULTS 
The E ffect of Undia.lyzed S upernatants on 3H Thym.idine 
Upta.l~e by HeLa Cells 
Condi tioned or spent media can stimulate proliferation cells 
in cul ture. Therefore, the effect of non dialyzed, pooled super-
natants ("conditioned media") from antigen-stimulated (active) 
and nonan tigen stimulated (control) PBMC of normaJ and 
psoriatic subjects on the replication of HeLa cells maintained 
in tissue cultme, was assessed by 3H thymidine incorporation. 
The data of Table I generally show that active supernatants of 
antigen-stimulated PBMC from both normal and psoriatic sub-
jects, have more cytostatic activity than the corresponding 
control supernatants. At the lower dilutions, both active and 
control supernatants from psoriatic subjects are significantly 
TABLE 1. Effect of u.ndia.lyzed pooled lymphohine", a.ctive a.nd control" , normal v.s. psoriasis, on 3H thymidine upta.he by H eLa cell cultures: 
Percent of Ineclia" 
Dilution of test IYlllphokine" 
Lymphokine sOlll'ce 
1:1 ]:4 1:1 6 1:64 
Norma l active 25 ± 8" 41 ± 8 56 ± 10 64 ± 10 
Normal control 40 ± 6 51 ± 10 73 ± 13 72 ± II 
Psor iasis active 54 ± 10 73 ± 16 82 ± 26 103 ± 20 
Psoriasis control 85 ± 18 105 ± 22 109 + 21 107 ± 21 
" Like samples pooled from 13 norma l and 13 psoriatic subjects. 
b Ac tive = supernata nts hal'vested at 96 h1' from antigen-stimulated PB MC. Control = supernatants harvested from PBMC without Ag at 96 
hI' and antigen reconstituted. 
c Data expressed as a percent of uptake of HeLa cells in media alone ± SEM. Each value is mea n of supernatants on 5 HeLa cell cultures-each 
done in triplicate. 
d Supernatants diluted with fresh med ia RPMI-1640 wi th penicillin and st.reptoll)ycin. 
e S ign ificance (paired t-test, 2-ta il) . 
1:1 
Norma] active vs. psoriasis active < 0.02 
Norma.! control vs. psoriasis control < 0.05 
Normal active vs. nonna l control < 0.05 
PSOl'iasis active vs. psoriasis control < 0.1 < 0.05 
1:4 
< 0.05 
<0.05 
NS 
<0.01 
\ :16 \:64 
NS < 0.05 
NS NS 
<0.02 <0. 1 < 0.05 
NS < 0.1 < 0.05 
150 KRUEGER AND JEDERBERG 
less inhibitory t han similar supernatants Ii'om normal subjects. 
When supernatants are diluted with fresh media to 1:64 and 
more, the inhibitory activity is lost. There is no difference in 
activity between the PBMC supernatants that have been re-
constituted with antigen, and those not reconstituted (see 
Methods, Aliquots B and C). The addition of antigen to HeLa 
cell cultures does not effect 3H thymidine incorporation; there-
fore, t he non antigen reconstituted Iymphokine (Aliquot C) is 
not included in data analysis. 
Effect of Dialyzed Supernatants on 3H Thymidine Uptahe by 
HeLa Cell Cultures 
To further assess the potential role of these observations 
being secondary to spent media effects, pooled supernatants 
were dialyzed against fresh media and assayed on 7 separate 
occasions in triplicate (see Table II). The normal control , pso-
riasis active, and psoriasis control, supernatants do not have as 
much inhibitory activity as the undialyzed component. How-
ever, the uptake of 3B thymidine .with normal active superna-
tants is similar to that seen with the undialyzed coun terpart. 
At the 1:1 dilution, the active supernatan ts fi'om psoriatic 
subjects a re much less inhibitory (85% of the uptake seen in 
cells gTOwn in media) than the active supernatants from normal 
subjects (29%). As the supernatants are dilu ted, enhancement 
of 3H thymid ine incorporation occurs. Beyond 1:64, 3B thy-
midine incorporation begins to return to baseline, i.e., that seen 
with B eLa cells grown in media. At these higher dilutions, the 
significant dichotomous differences, normal vs. psoriasis, are no 
longer present. Baseline is reached at dilutions of 1:500 or more. 
When data are analyzed, not as a percentage of activity in 
media alone, but as an index of activity of control supernatants 
(CPM active supernatants/CPM control supernatants), sepa-
rately for normal and psoriatic subjects, psoriatic subjects are 
noted to produce approximately 30% less PIF activity than 
control subjects at the 1:1 dilution (p < 0.02, paired t-test, 2-
Vol. 74, No.3 
tail). As the supernatants are diluted, these indices become 
similar, normal vs. psoriasis. 
Analysis of Individual Supernatants and 3H Thymidine 
Uptahe by HeLa Cell Cultures 
To determine whether the pooled data were representative 
of the individual supernatants, active and control dialyzed 
supernatants from each individual subject were tested on 2 
occasions in triplicate. Some of the individual supernatants 
displayed their most inhibitory or least inhibitory effect as 
concentrations other than those expected, i.e. 1:1 or 1:64. There-
fore, data are presented as mean values of the concentrations 
that are most inhibitory and least inhibitory, Table III. These 
data demonstrate signifi cant differences between normal and 
psoriasis, and confirm the data of the experiments where pooled 
supernatants were used . 
Comparison of the Effect of Supernatants on Cell 
Proliferation 
To determine whether 3B thymidine uptake accurately re-
fle cts the effect of the supernatants on cell proliferation in these 
experiments, assessment of the actual number of cells was 
carried out via microscopic analysis (see Table IV). When 
compared with media alone, the undiluted, pooled, dialyzed 
supernatants from normal subjects were very effective in in-
hibiting the proliferation of cells at 48 hr, p < 0.01. On the other 
hand, both supernatant preparations from psoriatic subjects, as 
well as the control supernatants from normal subjects, showed 
enhancement. 
Kinetics of Inhibition vs. Enhancement of HeLa Cell 
Proliferation by Supernatants 
The following experiment was undertaken to determine 
whether there were differences in the kinetics of inhibition or 
enhancement of proliferation by these supernatants. The effect 
TABLE n. Effeci of dialyzed pooled lympholline", active and control", nonnal vs. psoriasis, on 3H thytnidine uplalle by HeLa cell cultures, 
percen.t of media" 
Test Iymphokine 
Normal active 
Normal control 
Psoriasis active 
Psoriasis control 
" See Table I-Supernatants dialyzed X 3 - See Methods. 
/> See Table I. 
,. See Table I: n = 7 in this experimental series. 
" See Table 1. 
" Significance (paired l-test, 2-tail ). 
Normal active vs. psoriasis active 
Normal control vs. psoriasis control 
Normal active vs. normal control 
Psoriasis active vs. psoriasis control 
1:1 
29 ± 5" 
86 ± 23 
85 ± 17 
124 ± 24 
1:1 
< 0.02 
NS 
< 0.05 
<0.02 
Dilution of test Iymphok ine" 
1:4 l:l6 1:64 
69 ± 10 101±17 120 ± 20 
105 ± 20 128 ± 23 138 ± 25 
91 ± 16 120 ± 23 132 ± 24 
144 ± 27 157 ± 26 160 ± 30 
1:4 1:16 1:64 < 1:64 
< 0.05 <0.02 NS NS 
<0.02 NS <0. 1 < 0.05 NS 
< 0.02 < 0.01 <0.02 NS 
<0.05 <0.05 NS NS 
TABLE III. Effect of individual aliq llots of lymphohine", a.ctive and control" norm.a.l vs. psoriasis, on 3H thym.idine uptahe by 
HeLa cell cultures" 
Mean va lues or individual SlIpel'llntants ut most inhibitol'Y unci least. inhibitory concentration 
Most Inhibition % of Media ± SEM 
Psoriasis active 
Psoriasis control 
Psoriasis active 
Psoriasis con tro l 
74 ± 6 
94 ± 3 
105±4 
115±4 
Least inhibi tion 
" Individua l a liquots dia lyzed (12 psoriasis, 13 normal) tested without pooling. 
/, See Tables I and II. 
55 ± 4" 
65 ± 5" 
87 ± 4" 
90 ± 5f 
,. Data expressed as the mean % uptake of 3H thymidine c.f. media alone 0(' 2 different triplicate assays. 
d p < 0.05 ( tudent I-test, 2-ta il ). 
,. p < 0.001 (Student t-test, 2-tail). 
f p < 0.005 (Student l-test, 2-ta il) . 
Normal active 
Normal control 
Normal active 
Normal control 
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of pulsing with the various pooled dialyzed supernatants for 24 
hr followed by a pulse with media for 24 hI', is illustrated in the 
Fi~ure, a. This is compared with an experimental procedure 
where m edia was added initially and replaced by their respec-
tive pooled supernatan t at 24 hr (Figure c). The pattem of 
normal active and normal control supernatants having more 
inhibitory activity than the counterparts from pa tients with 
ps oriasis is again apparent. Both the inhibitory and proliferative 
phenomena are present when H eLa cells were ini tially pulsed 
wi t h supernatants and then replaced with media (Figure, a ). 
However, when media was ini tially added, followed by super-
natan ts a t 24 hI', neither the inhibitory nor the proliferative 
effects a re apparent (Figure, c) . Data in Figure 1 are expressed 
as CPM's to illustrate the variabili ty within an assay, as well as 
t o illustrate the effect of pulsing with supem atant. 
The kinetics of the reaction and the ability of HeLa cells to 
bind proliferative factor(s), as well as inhibitory fac tor(s), ap-
p ear to be the same, normal vs. psoriasis (Figure ). T o ascertain 
whether PBMC supernatants migh t have their effect by not 
p e rmitting HeLa cells to adhere;supernatants were added prior 
t o (no 4-hr pre-incubation of HeLa cells in media ) the addition 
of H eLa cells (data not presented) . One or 4 hI' after the 
a ddition of superna tants, the plates were centrifuged and su-
perna tants removed, and replaced with media, new superna-
t ants, or the superna tants were left in place. Centrifugation did 
T A BLE IV. Comparison of the effect of d ia ly zed p ooled lymphokine", 
a ct ive and control", norm.a l vs. p soriasis, on proliferation of H eLa 
cells in culture 
# of cells (x lOY % of media" 
Media alone at t ime 0 
M edia alone at 48 hI' 
Normal ac tive lymphokine 
Norma l contl'Ol Iymph okine 
Psoriasis active lymphokine 
Psorias is cont rol lymphokine 
" See T able 1. 
" See T able 1. 
0.5 ± 0.05 
2.34 ± 0.05 
1.36 ± 0. 10 
3.01 ± 0.12 
2.57 ± 0. 16 
3.06 ± 0.07 
57" 
130" 
109" 
130" 
C Actual # of cells added pel' well of 24 well costar pla te-mean of 
d uplicate experiments ± SEM. 
# of HeLa cells grown in media a lone 
" x 100 # of H eLa Cella grown in presence of lymphokine . 
C S ignificance p < 0.05 c.r. media (by Chi-squar e analysis). 
r Significnce p < 0.05 c.f. norma l ac tive (by Chi-square analysis). 
not effect 3H thymidine incorporation , i.e., cells al lowed to 
settle in the wells, or forced to settle with centrifugation, had 
very simila r values, relative to their respective supernatants. 
These additional data show that either a l or 4 hr pulse, without 
the 4 hI' presettling of the HeLa cells had the same effect as the 
24- h1' pulse. This, relative to both the inhibition and enhance-
ment of cell proliferation for supernatants of normal and pso-
riatic subjects (FigUl'e). 
The E ffect of Washin.g, Following a 4-hr Pulse with 
S upernatants 
In an effort to differentiate the inhjbi tion and enhancement 
seen in this experiment, cultures were pulsed for 4 h1' with the 
various pooled dialyzed supernatants or fresh media and 
washed 2 times by centrifugation and resuspension in fresh 
media. Results are compared with cultures treated in a similar 
manner , bu t not washed (T able V) . A 4-1U' pulse, Panel A, 
T able V, demonstrates the expected effect. Panel B suggests 
that washing times 2, and then replacing with fresh superna-
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DILUTIONS OF LYMPHOKINE 
P ulse study: P a.n.el a-Lymphol, ine (PIF) anden ini tia lly, withdrawn 
at 24 hI' a nd replaced wi th media. Panel b-Lym phokine (PIP) added 
ini t ia lly, withdrawn a nd replaced with lymphokine (PIP) at 24 hr. 
Panel c, M edia added ini tia lly, withdrawn and replaced with Iympho-
kine (PI P) at 24 hr. Values (cpm x 10-") repre ent mean of' a n 
experiment done in triplicate ± SD. 
TABLE V. Effect of washing HeL a. cells+ after 4- 11.1' pulse" on 3H thymidine incorporation, comparing d ia lyzed lymphokill e, active alld 
contfol, norm.a l vs. psoriasis", a.t I : I dilution, percent of m.ediad 
A. Lymphokine (PIF) added a t time 0, centrifuged a t 4 hr-supernatants not removed 
Lymphokine Source 
Normal active 38 ± 4 
Normal control 53 ± 8 
Psoriasis active 55 ± 9 
P soriasis control ll5 ± 11 
B . Lymphokine added at time 0 , removed at 4 hI', replaced wi th fresh original supernatants 
Lymphokine SouTce No Wash Wash x2 
Normal active 47 ± 16 75 ± 11 
Normal control 44 ± 18 69 ± 5 
Psoriasis active 52 ± 10 105 ± 3 
Psoriasis control 102 ± 7 103 ± 4 
C. Lymphokine added at time 0, rem oved at 4 hI', r eplaced with fresh media 
Lymphokine source No wash 
Normal active 58 ± 8 
Norma l control 83 ± 12 
Psoriasis active 84 ± 3 
Psoriasis control 159 ± 15 
" See Methods-HeLa cells added to chambers 4 hI' prior to addit ion of upernatants. 
Wash x2 
143 ± 12 
86 ± 16 
173 ± 3 
91 ± 6 
"4 hl' a fter supernatants added, microtite r pla tes centrifuged and: (A) supernatants not removed, (B) supernatants removed and replaced with 
same fluids as added ini tia lly, (el supernatants removed a nd replaced wi th media; In experiments Band C, 1 set washed >.:2, 1 set not washed. 
C See T ables I and II. 
d See T able IV, values are mean of duplicate experiments performed in t riplicate. Mean CPM in media alone in No Wash series = 25,800; and 
in Wash series, i.e., wi th fresh media each lime = 26,900; in centrifuge without wash, centrifuge x2 = 26, 100; centri fuge x 3-28,400. 
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tants ident ical to those of the initial 4-hr pulse provides an 
advantage to factors which enhance the proliferation. Washing 
the cells times 2 to remove the supernatant effect agai n dem-
onstrates that the enhancing effect is preferential, Panel C. 
Differences between the wash and no-wash experiments are 
s ignificant (p < 0.01, pai.red t-test, 2-tail , Panel C, Table V). 
These data are in harmony with the concept that HeLa cells 
have preference for the factor(s) in supernatants which en-
hances the uptake of 3H thymidine. Further, more of the 
factor(s) which enhances proliferation is made when PBMC are 
antigen-stimulated than when not stimulated. This is demon-
strated in the wash column of Panel C, Table V, where antigen-
stimulated lymphokine shows more enhancement than nonan-
tigen stimulated controls for both normal and psoriasis (143% 
vs. 86%, and 173% vs. 91%, respectively) . 
DISCUSSION 
Clinicians feel that epidermal hyperplasia routinely fo llows 
inflammatory injury to the skin; however, experimental evi-
dence for this observation, othei' than routine histology, is 
lacking [24,25), Mononuclear cells, particul arly macrophages, 
and their solu ble products, appear to be vital in the proliferation 
wh ich accompanies wound heaJing [18]. T hat these factors also 
cause normal epidermal hyperplasia, or the induction/ mainte-
nance of lesions of psoriasis, is plausible, but also, as yet, 
without experimental evidence. Data in this paper correlate 
with what wou ld be expected, mononuclear cells from patients 
with a large part of the il' body surfaces involved in a disease of 
excess cellular proliferatio n produce less of the factor(s) which 
inh ibits the proli feration of B eLa cell cul t ures (Tables II and 
V). 
The concept of stimuJated mononuclear ce lls producing fac-
tors which can both enhance and suppress cell proliferation for 
the immune system has gained ready acceptance [26]. However, 
the idea that such products inhibit cell proliferation, other t han 
the immune system, is being accepted less readily [7-17). At-
tracting less attention is the observation that components of 
PBMC isolation , especially platelets and monocytes, apperu' to 
produce factors which enhance fibroblast and endothelial pro-
liferation [18,19,27,28]. Whether the factors which a ppeal' to 
have opposite effects are produced by the same cell undergoing 
similar types of stimulatory responses is unknown (for review, 
see Unanue [29], and Waksman [22]). 
The mechan ism whereby such factors effect cell prolifera-
tion/ differentiation is a lso unknown. Recent stud ies suggest 
lymphokines can enhance and suppress fibroblast proliferation, 
and may correlate with the cell line tested, tra nsformed vs. 
nontransformed [30,31]. In both stud ies, lymphokine stimulated 
collagen production. Lymphokines augme nt the release of lym-
phokine, and inhibi t proliferation. These lymphokines appear 
to move cells from the G-O phase to the G-l phase of the cell 
cycle. If receptors exist, other lymphokines appear to act in the 
post-G-l component of the cell cycle [28,32]. These observations 
appear to support the rather simplistic concept of the "net 
effect" being t he important in vivo correlation. If th e "net 
effect" of mediator release is enhancement of proliferation, this 
occurs while the opposite OCC UI'S if the "net effect" is suppres-
sion of proliferation. 
Although appa rent ly ge netically acquired, psoriasis comes on 
relatively late, between the ages of 10 and 30 [4]. It flares and 
remits spontaneously and can be readiJy induced with specific 
trauma at times, and not at others [1,4], suggesting modifying 
0 1' compensatory influe nces are playing a role in this disease. 
Unfortunately, there is no method to recognize early events of 
fl a re or remission of psoriasis. Thus, the state or potential 
compensatory mechanisms are unknown in our subjects. There 
is no correlation between either the inhibit ion 01' enhancement 
of cell proliferation by these supernatants and the delayed 
intradermal skin tests. Further, there is no correlation between 
the degree or state of psoriasis, and the a bnormal mononuclear 
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cell function (depressed responsiveness to skin tests, mitogen 
and mixed lymphocyte reactions, or wi th monocyte chemotaxis 
or monocyte reduction of NBT) that we and others have 
previously reported [20,21,33-37]. 
Supernatants from antigen-stimulated PBMC were utilized, 
rather than mitogen-stimulated PBMC, because an tigens are 
more physiologic agents. Nonspecific mitogens, such as PHA, 
can stimulate proliferative events by themselves [31]. Data, not 
presented, demonstrate that when the an tigens used in these 
experiments were added at various doses (up to 2.5 X ) to the 
HeLa cell cultw'es, no effect on 3H thymidine incorporation 
was noted . There was no correlation between PIF activi ty and 
the type of an tigen used, an observation supported by similar 
data seen when another lymphokine (lymphocyte-derived ch e-
motactic factor) was similarly generated and quantitated [21]. 
S upernatants were tested without fwther purification to deter-
mine "net effect", i.e., whether or not the whole supernatan t 
from PBMC h ad an overriding influence of one type or another. 
Distribution of the number of antigens used, i. e., the number of 
subjects stimulated with SKSD, PPD, etc., amongst the test 
population, did not account for th e reported differences, normal 
vs. psoriasis. Objections can be raised to our choice of u tilizing 
different an tigens; however, an eq ually, or more, objectionable 
choice would be the use of the same ant igens with their varying 
responses. In some subjects, some an tigens elicited no response; 
thus, the onJy choice seemed to be that which we made. 
Activity was enhanced by diaJysis, suggesting the factor(s) 
released by antigen-stimulated PBMC effecting cell prolifera-
tion has a molecular weight of greater than 10,000 (i.e. they are 
appru"ently not prostaglandins 0 1' nucleosides). Condi t ioned me-
dia does alter activity; both th e inhibitory and proliferative 
events are more pronounced following dialysis. The exception 
is undilu ted, active supernatants from normals. Data, not pre-
sented, from supernatants concentrated times 5, demonstrate 
onJy 20% more inhibitory activity than seen with unconcen -
trated samples. The failure to detect a difference in protein 
concentration, predialysis compared with postdialysis, suggests 
t hat th e increase in protein concentration, secondary to dialysis, 
had a negligible effect on the generation of t he data. The 
nonlineari ty of t he 5x concentra tion weighs in favor of severaJ 
factors being involved in some type of competitive role in our 
observations. 
Most data al"e expressed as a percent of media, rather than 
as an index of act ive vs. control. This was done to facilitate 
comparison of the response of PBMC of normal and psoriatic 
subjects to antigenic stimulation . Using t his method of com-
parison, normaJ vs. psoriasis, another concept emerges; unstim-
ulated PBMC produce factors which effect cell proliferation. 
T he data of Table II demonstrate that with dilu tion, factors 
effecting proliferation are more in evidence. If eq ual amounts 
and both had equal effects on cells, values should no t exceed 
100%. The factor(s) which causes proliferation appears to have 
a greater effect on HeLa cells than does the factor(s) which 
causes inhibi tion (dilutional data and wash experiments-Table 
V) . The effect of supernatan ts on cell counts (Table IV) sup-
ports the use of 3H thymidine as an indicato r of HeLa cell 
proliferation in t his assay system. 
T he failure to see an effect when supernatants were added at 
24 hr, a time when confluence of growth is being a pproached, 
suggests other factors are emerging as a function of time, which 
also playa role in the kinetics of cell proliferation in this in 
vitro system. That mononuclear cell supernatants will onJy 
influence cell growth during the expotentia l phase of growth 
i.e. 0-20 hours, is suggested by our data. However, definitiv~ 
data will have to await results of further experiments. 
The possibility that t he limited number of experiments to 
quantitate PIF in individuals is not representative appears 
unJikely. Another lymphokine (lymphocyte-derived chemotac-
tic factor) previously repor ted [21] was quantitated in these 
and other psoriatic subjects. A good correlation exists between 
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the quantitative assessment of these two lymphokines in indi-
vidual subjects (r = 0.56, p < 0.01). 
The observations reported in t his paper support the concept 
that inflammato ry events playa rol e in the enhancement and 
suppression of cell proliferation. Whether these events are 
regulated by separate molecular substances is unknown. We 
feel the dilutional data (Table II) and the pulse wash experi-
ments (Table V) support separate fa ctors for inhibit ion and 
enhancement of HeLa cell proliferation in vitro. Using cells 
from peripheral blood, our data support the possibility that 
psoriasis may result from an aberration of mediator release; 
however, more experimental data are needed to permit t hese 
conclusions. 
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